Good news for stem cell therapies
Brazilian researchers at D’OR Institute for Research and Education (IDOR) and Federal University of Rio de Janeiro (UFRJ) have taken what they describe as an important step toward using the…
GDNF not needed by the midbrain dopamine system
A key factor in the motor symptoms associated with Parkinson’s disease is the gradual destruction of dopamine neurons. The glial cell-derived neurotrophic factor, or GDNF, has been proven to protect…
Sticky peptide may help Parkinson’s
In Parkinson’s, a protein called α-synuclein becomes misshapen and stacks together to form long toxic fibrils that kill the brain cells. A team of scientists led by the University of…
Skin test may shed new light on Alzheimer’s and Parkinson’s diseases
The 24th February issue of Science Daily reports that scientists at the Central Hospital at the University of San Luis Potosi in San Luis Potosi, Mexico have found that skin…
New growth factor indicates possible regenerative effects in Parkinson’s disease
Credit: Image courtesy of Lund University Science Today reports that researchers at Lund University and Karolinska Institutet have, in a first-in-human clinical study with twelve participating patients, applied a growth…
New therapeutic principle for dyskinesia shows clinical effect
Involuntary dyskinetic movements induced by treatment with levodopa (L-dopa) are a common problem for people with Parkinson’s disease. Science Today reports that researchers at Karolinska Institutet and Lund University in…
- « Previous Page
- 1
- ...
- 10
- 11
- 12
- 13
- 14
- ...
- 20
- ...
- 23
- Next Page »